DBV Technologies S.A. (EPA:DBV)
1.148
+0.022 (1.95%)
Apr 1, 2025, 3:47 PM CET
DBV Technologies Employees
As of December 31, 2023, DBV Technologies had 105 total employees, including 104 full-time and 1 part-time employees. The number of employees increased by 19 or 22.09% compared to the previous year.
Employees
105
Change (1Y)
19
Growth (1Y)
22.09%
Revenue / Employee
€37,563
Profits / Employee
€1,018,667
Market Cap
115.47M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
Sanofi | 82,878 |
EssilorLuxottica Société anonyme | 153,498 |
Sartorius Stedim Biotech | 9,901 |
bioMérieux | 14,754 |
Eurofins Scientific SE | 62,696 |
Ipsen | 5,358 |
Virbac | 5,620 |
emeis Société anonyme | 77,954 |
DBV Technologies News
- 3 days ago - Why DBV Technologies (DBVT) Stock Is Skyrocketing - Benzinga
- 4 days ago - DBV Technologies ADRs Rise After Up to $306.9M in New Financing - Market Watch
- 4 days ago - DBV Technologies announces up to $307M financing to advance Viaskin Peanut program - Seeking Alpha
- 4 days ago - DBV Technologies Announces Financing of up to $306.9 Million (€284.5 Million) to Advance Viaskin® Peanut Patch Through Biologics License Application Submission and U.S. Commercial Launch, if Approved - GlobeNewsWire
- 8 days ago - DBV Technologies Secures Agreement with FDA on Safety Exposure Data Required for BLA for Viaskin® Peanut Patch in 4–7-year-olds, Accelerating the Timeline for a BLA Filing Submission to 1H 2026, & Reports 2024 Unaudited Financial Results - GlobeNewsWire
- 4 weeks ago - DBV Technologies to Participate in Upcoming AAAAI/WAO Joint Congress - GlobeNewsWire
- 2 months ago - Half-Year Report on the DBV Technologies Liquidity Contract with ODDO BHF - GlobeNewsWire
- 3 months ago - DBV Aligns With FDA On Accelerated Approval For Viaskin Peanut Patch In Younger Kids - Benzinga